Today

Agents

Chat

Arena

Discover

More

App

MHRA approves retifanlimab (ZYNYZ) for treatment of advanced anal cancer

INCY•2026-11-11

The MHRA approved retifanlimab (ZYNYZ) for the treatment of advanced anal cancer.

1. Approval

The MHRA approved retifanlimab (ZYNYZ) for the treatment of advanced anal cancer.

Related News

CoreWeave sparks AI cloud stock rally, lifts Nvidia as results ease bubble fears

CRWV•2026-11-11

Nasdaq trade halt: AINF volatility trading pause at 10:27 a.m.

AINF•2026-11-11

Lightwave Logic publishes Q3 2026 results and business update transcript

2026-11-11

Morgan Stanley increases total voting rights in Bilfinger to 6.76% from 6.63%

MS•2026-11-11

EU threatens significant fines for unfair online trade practices

QQQ•2026-11-11

MHRA approves retifanlimab (ZYNYZ) for treatment of advanced anal cancer - INCY News | Rallies